However, inflammation in humans is the result of an imbalance in the complex interaction between pro- and anti-inflammatory pathways as well as microbial alterations, and while loss of IL10 is seen only in some very early onset monogenetic IBD cases, loss of IDO1 has not been reported. Here, IL10 is linked to inflammatory bowel disease.